Position in MRNA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$68,870,998
+$27,710,147 QoQ
Shares Held
983,450
+21.4% QoQ
Ownership
0.246%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#36
of 777 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. MRNA ranks #10 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in MRNA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68,870,998 | 983,450 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $41,160,851 | 810,253 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $33,031,480 | 1,120,091 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $32,620,368 | 1,262,887 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $33,086,835 | 1,199,233 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $49,254,295 | 1,737,365 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $78,755,635 | 1,894,075 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $81,830,725 | 1,224,461 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $124,021,427 | 1,044,391 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $103,597,841 | 972,202 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $102,941,683 | 1,035,110 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $78,731,970 | 762,242 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $160,405,997 | 1,320,214 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $278,096,974 | 1,810,763 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $329,455,227 | 1,834,179 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $268,854,853 | 2,273,614 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $288,198,871 | 2,017,493 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $310,939,804 | 1,805,061 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $236,213,841 | 930,049 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $417,545,002 | 1,084,927 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $172,049,062 | 732,186 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $71,401,664 | 545,259 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $58,803,027 | 562,870 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $28,528,025 | 403,223 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $18,925,960 | 294,751 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,677,769 | 122,797 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||